Skip to main content
. 2021 Jul 30;8:692120. doi: 10.3389/fmolb.2021.692120

FIGURE 5.

FIGURE 5

The prognostic impact of COL1A1 in 33 types of human tumors were examined using GEPIA2. (A) High expression of COL1A1 was associated with poor overall survival in KIRP (HR = 2.2, p = 0.011), LGG (HR = 2, p = 0.00028), MESO (HR = 2.2, p = 0.0014), SKCM (HR = 1.5, p = 0.0032), and STAD (HR = 1.5, p = 0.013). (B) High expression of COL1A1 was associated with poor disease-free survival in CESC (HR = 2, p = 0.018), COAD (HR = 1.6, p = 0.041), ESCA (HR = 1.6, p = 0.045), KIRP (HR = 3.1, p < 0.001), LGG (HR = 1.4, p = 0.024), and PRAD (HR = 2, p = 0.0011).